These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8815836)

  • 21. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental models.
    Meuleman DG
    Semin Thromb Hemost; 1989 Oct; 15(4):370-2. PubMed ID: 2479103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment of deep vein thrombosis and pulmonary embolism.
    Turkstra F; Koopman MM; Büller HR
    Thromb Haemost; 1997 Jul; 78(1):489-96. PubMed ID: 9198202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Which antithrombotic agents should be prescribed in deep venous thrombosis of the limbs?].
    Fiessinger JN
    Presse Med; 1994 Mar; 23(11):509-10. PubMed ID: 8022737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
    Prandoni P
    Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulant agents in the management of pulmonary embolism.
    Agnelli G; Sonaglia F
    Int J Cardiol; 1998 May; 65 Suppl 1():S95-8. PubMed ID: 9706837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation in the prevention and treatment of pulmonary embolism.
    Agnelli G
    Chest; 1995 Jan; 107(1 Suppl):39S-44S. PubMed ID: 7813328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Strategies for utilization of anticoagulants in pulmonary embolism].
    Fartoukh M; Simonneau G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):949-60. PubMed ID: 10907444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin and low molecular weight heparin for treatment of acute pulmonary embolism.
    Raskob GE
    Curr Opin Pulm Med; 1999 Jul; 5(4):216-21. PubMed ID: 10407690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of venous thromboembolism.
    ten Cate JW; Koopman MM; Prins MH; Büller HR
    Thromb Haemost; 1995 Jul; 74(1):197-203. PubMed ID: 8578457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulants: the state of the art.
    Gallus AS
    Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute pulmonary embolism.
    Stein PD
    Dis Mon; 1994 Sep; 40(9):467-523. PubMed ID: 8076500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism.
    Wells PS
    Curr Opin Pulm Med; 2001 Sep; 7(5):360-4. PubMed ID: 11584190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Subcutaneous recombinant hirudin in the treatment of deep venous thrombosis. A pharmacokinetic study].
    Schiele F; Vuillemenot A; Mouhat T; Kramarz P; Kieffer Y; Camez A; Bassand JP
    Arch Mal Coeur Vaiss; 1995 Mar; 88(3):329-35. PubMed ID: 7487286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
    ten Cate JW
    Haemostasis; 1992; 22(2):109-11. PubMed ID: 1379964
    [No Abstract]   [Full Text] [Related]  

  • 39. Antithrombotic therapy in deep vein thrombosis and pulmonary embolism.
    Hirsh J
    Am Heart J; 1992 Apr; 123(4 Pt 2):1115-22. PubMed ID: 1553881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight heparin fraction PK 10169: a new therapeutic means for anticoagulant therapy?
    Huet Y; Gouault-Heilmann M
    Haemostasis; 1986; 16(2):165-72. PubMed ID: 3710295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.